Covidien Ltd Completes Acquisition of VNUS Medical Technologies, Inc.
DUBLIN--(BUSINESS WIRE)--Covidien (NYSE: COV), a leading global provider of healthcare products, today announced that one of its subsidiaries has completed the previously announced acquisition of VNUS Medical Technologies for approximately $440 million, net of cash and investments acquired.